FR2480779B2
(fr)
*
|
1979-08-30 |
1986-07-18 |
Anvar |
Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
|
US6297355B1
(en)
*
|
1978-12-22 |
2001-10-02 |
Biogen, Inc. |
Polypeptides displaying HBV antigenicity or hbv antigen specificity
|
IE52036B1
(en)
*
|
1979-05-24 |
1987-05-27 |
Univ California |
Non-passageable viruses
|
USRE34705E
(en)
*
|
1979-08-30 |
1994-08-23 |
Institut Pasteur |
Nucleotidic sequence coding the surface antigen of the hepatitis B virus, vector containing said nucleotidic sequence, process allowing the obtention thereof and antigen obtained thereby
|
FR2495636B2
(fr)
*
|
1980-12-09 |
1989-10-06 |
Pasteur Institut |
Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
|
FR2480780B1
(fr)
*
|
1980-04-22 |
1985-12-06 |
Pasteur Institut |
Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
|
EP0038765B1
(fr)
*
|
1980-04-22 |
1987-09-02 |
Institut Pasteur |
Vaccin contre l'hépatite virale B, procédé et cellules eucaryotes transformées pour la production de ce vaccin
|
FI83662C
(fi)
*
|
1980-07-17 |
1991-08-12 |
Scripps Clinic Res |
Diagnostik antikropp och foerfarande foer dess framstaellning.
|
US5145782A
(en)
*
|
1980-12-08 |
1992-09-08 |
The Regents Of The University Of California |
DNA expression vector suitable for direct expression of a foreign gene
|
NZ199722A
(en)
|
1981-02-25 |
1985-12-13 |
Genentech Inc |
Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
|
EP0062286A1
(en)
*
|
1981-03-31 |
1982-10-13 |
Albert Einstein College Of Medicine Of Yeshiva University |
Diagnostic test for hepatitis B virus
|
US5332664A
(en)
*
|
1981-07-15 |
1994-07-26 |
Celltech Limited |
Human calcitonin precursor polyprotein structural gene
|
US4769238A
(en)
*
|
1981-08-04 |
1988-09-06 |
The Regents Of The University Of California |
Synthesis of human virus antigens by yeast
|
ATE53235T1
(de)
*
|
1981-08-04 |
1990-06-15 |
Univ California |
Synthese von menschlichen viralen antigenen mit hilfe von hefe.
|
GR76274B
(ru)
*
|
1981-08-04 |
1984-08-04 |
Univ California |
|
ZW18282A1
(en)
|
1981-08-31 |
1983-03-23 |
Genentech Inc |
Preparation of polypeptides in vertebrate cell culture
|
NZ201705A
(en)
*
|
1981-08-31 |
1986-03-14 |
Genentech Inc |
Recombinant dna method for production of hepatitis b surface antigen in yeast
|
US4803164A
(en)
*
|
1981-08-31 |
1989-02-07 |
Genentech, Inc. |
Preparation of hepatitis b surface antigen in yeast
|
AU8746582A
(en)
*
|
1981-09-02 |
1983-03-10 |
Biogen N.V. |
Hepatitis b virus e type antigen
|
JPS5890517A
(ja)
*
|
1981-11-24 |
1983-05-30 |
Japan Found Cancer |
B型肝炎ウイルスの表面抗原を合成する新規な組換え体及びその製法
|
US4741901A
(en)
*
|
1981-12-03 |
1988-05-03 |
Genentech, Inc. |
Preparation of polypeptides in vertebrate cell culture
|
US4603112A
(en)
*
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
US7767449B1
(en)
*
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
US4762708A
(en)
*
|
1982-02-18 |
1988-08-09 |
University Patents, Inc. |
Materials and methods for herpes simplex virus vaccination
|
AU1678783A
(en)
*
|
1982-07-20 |
1984-01-26 |
Molecular Genetics, Inc. |
Production of herpes simplex viral proteins
|
AU584580B2
(en)
*
|
1982-09-08 |
1989-06-01 |
Smith Kline - Rit |
Hepatitis B virus vaccine
|
US4820642A
(en)
*
|
1983-04-04 |
1989-04-11 |
The Regents Of The University Of California |
Amplified expression vector
|
GB8321789D0
(en)
*
|
1983-08-12 |
1983-09-14 |
Biogen Nv |
Vaccines and compositions against hepatitis
|
FR2560890B1
(fr)
*
|
1984-03-07 |
1987-10-16 |
Grp Genie Genetique |
Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
|
WO1985004103A1
(en)
*
|
1984-03-09 |
1985-09-26 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants
|
NZ212207A
(en)
*
|
1984-05-31 |
1991-07-26 |
Genentech Inc |
Recombinant lymphotoxin
|
US5683688A
(en)
*
|
1984-05-31 |
1997-11-04 |
Genentech, Inc. |
Unglycosylated recombinant human lymphotoxin polypeptides and compositions
|
EP0401941A3
(en)
*
|
1984-07-11 |
1991-04-17 |
Takeda Chemical Industries, Ltd. |
Hepatitis b virus surface antigen and production thereof
|
US4769239A
(en)
*
|
1984-08-21 |
1988-09-06 |
Merck & Co., Inc. |
Vaccine against varicella-zoster virus
|
US9328391B1
(en)
*
|
1984-08-22 |
2016-05-03 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Cloning and expression of HIV-1 DNA
|
US4722840A
(en)
*
|
1984-09-12 |
1988-02-02 |
Chiron Corporation |
Hybrid particle immunogens
|
JPS6170989A
(ja)
*
|
1984-09-13 |
1986-04-11 |
Takeda Chem Ind Ltd |
組み換えdnaおよびその用途
|
JPS6226300A
(ja)
*
|
1984-10-10 |
1987-02-04 |
セントコ−・インコ−ポレ−テツド |
Htlv−3dnaのクロ−ニングおよび発現
|
GB8431171D0
(en)
*
|
1984-12-11 |
1985-01-23 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
US6534285B1
(en)
|
1984-12-24 |
2003-03-18 |
Genentech, Inc. |
Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
|
JPS61233700A
(ja)
*
|
1984-12-24 |
1986-10-17 |
ジエネンテク,インコ−ポレイテツド |
分子クロ−ンされたエイズ関連ポリペプチド
|
US5853978A
(en)
*
|
1985-12-04 |
1998-12-29 |
Genentech, Inc. |
Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
|
FI861417A0
(fi)
*
|
1985-04-15 |
1986-04-01 |
Endotronics Inc |
Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
|
JPH084507B2
(ja)
*
|
1985-10-03 |
1996-01-24 |
武田薬品工業株式会社 |
新規dnaおよびポリペプチド
|
JPS62236496A
(ja)
*
|
1986-04-07 |
1987-10-16 |
Green Cross Corp:The |
HBsAgの製造方法
|
CA1310602C
(en)
*
|
1986-06-03 |
1992-11-24 |
Hajime Horii |
Yeast promoter and process for preparing heterologous protein
|
JP2661044B2
(ja)
*
|
1986-06-17 |
1997-10-08 |
カイロン コーポレイション |
肝炎δの診断薬およびワクチン
|
JPS63214181A
(ja)
*
|
1986-07-23 |
1988-09-06 |
ベ−リングベルケ、アクチエンゲゼルシャフト |
ヒト・パピロ−マ・ウイルス18型の発現生成物、これらのタンパク質に特異的な抗体およびこれらの抗体または対応するdnaを含む診断助剤
|
US4818688A
(en)
*
|
1986-11-21 |
1989-04-04 |
E. I. Du Pont De Nemours And Company |
Assays for antibody to hepatitis B core antigen
|
NZ219515A
(en)
*
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
CA1340173C
(en)
*
|
1987-03-10 |
1998-12-08 |
Chudi Guan |
Production and purification of a protein fused to a binding protein
|
ATE207535T1
(de)
*
|
1987-06-22 |
2001-11-15 |
Medeva Holdings Bv |
Hepatitis-b-oberflächenantigen enthaltendes peptid
|
US4880750A
(en)
*
|
1987-07-09 |
1989-11-14 |
Miragen, Inc. |
Individual-specific antibody identification methods
|
EP0402354A4
(en)
*
|
1987-08-10 |
1991-03-20 |
The University Of Melbourne |
Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine
|
EP0311228A3
(en)
*
|
1987-10-09 |
1990-05-02 |
Repligen Corporation |
Recombinant polypeptides and their uses, including assay for aids virus
|
JP2791418B2
(ja)
|
1987-12-02 |
1998-08-27 |
株式会社ミドリ十字 |
異種蛋白質の製造方法、組換えdna、形質転換体
|
EP0491077A1
(en)
*
|
1990-12-19 |
1992-06-24 |
Medeva Holdings B.V. |
A composition used as a therapeutic agent against chronic viral hepatic diseases
|
DE4107612A1
(de)
|
1991-03-09 |
1992-09-10 |
Behringwerke Ag |
Rekombinante proteine mit der immunreaktivitaet des hepatitis b virus e antigens (hbeag), verfahren zu ihrer herstellung und ihre verwendung in immunoassays und impfstoffen
|
US5175094A
(en)
*
|
1991-08-01 |
1992-12-29 |
Becton Dickinson And Company |
Increased expression of HBcAg
|
US5173427A
(en)
*
|
1991-08-01 |
1992-12-22 |
Becton Dickinson And Company |
Vectors and hosts with increased expression of HBCAG
|
US5175272A
(en)
*
|
1991-08-01 |
1992-12-29 |
Becton Dickinson And Company |
DNA sequences with increased expression of HBcAg
|
US5780036A
(en)
*
|
1991-08-26 |
1998-07-14 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
|
US6607727B1
(en)
|
1991-08-26 |
2003-08-19 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
|
US6297048B1
(en)
|
1992-02-04 |
2001-10-02 |
Chiron Corporation |
Hepatitis therapeutics
|
EP0591548A4
(en)
*
|
1992-03-30 |
1999-04-28 |
Suntory Ltd |
Anti-hbs antibody gene and expression plasmid thereof
|
US6235288B1
(en)
|
1992-08-26 |
2001-05-22 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
|
FR2711670B1
(fr)
*
|
1993-10-22 |
1996-01-12 |
Pasteur Institut |
Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
|
US5726011A
(en)
*
|
1994-03-31 |
1998-03-10 |
Virginia Commonwealth University |
Method for diagnosing chronic hepatitis B virus infection
|
RU2370541C2
(ru)
*
|
1994-12-09 |
2009-10-20 |
Имерджент Продакт Дивелопмент Юк Лимитед |
Vgc2 днк salmonella typhimurium, мутантная бактерия, обладающая пониженной способностью к адаптации к условиям окружающей среды, и способ ее получения
|
US5993820A
(en)
*
|
1996-11-12 |
1999-11-30 |
Michigan State University |
Chimeric LTB vaccines
|
US20030100520A1
(en)
*
|
1997-01-21 |
2003-05-29 |
Philip Needleman |
Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
|
GB9712370D0
(en)
|
1997-06-14 |
1997-08-13 |
Aepact Ltd |
Therapeutic systems
|
ID26669A
(id)
|
1998-02-12 |
2001-01-25 |
Immune Complex Corp |
Inti protein-protein hepatitis b yang dimodifikasi secara strategi dan turunan-turunannya
|
JP2002511257A
(ja)
*
|
1998-04-14 |
2002-04-16 |
カイロン コーポレイション |
目的の遺伝子を発現するための非クローニング技術
|
EP1108034B1
(en)
*
|
1998-09-04 |
2008-08-06 |
Emergent Product Development UK Limited |
Attenuated salmonella spi2 mutants as antigen carriers
|
PL348766A1
(en)
|
1998-12-04 |
2002-06-03 |
Biogen |
Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
|
US6551820B1
(en)
*
|
1998-12-23 |
2003-04-22 |
Boyce Thompson Institute For Plant Research |
Expression of immunogenic hepatitis B surface antigens in transgenic plants
|
GB9910812D0
(en)
*
|
1999-05-10 |
1999-07-07 |
Microscience Ltd |
Vaccine composition
|
US6268178B1
(en)
|
1999-05-25 |
2001-07-31 |
Phage Biotechnology Corp. |
Phage-dependent super-production of biologically active protein and peptides
|
GB0008419D0
(en)
*
|
2000-04-05 |
2000-05-24 |
Bioinvent Int Ab |
A method for invitro molecular evolution of antibody function
|
GB0008966D0
(en)
*
|
2000-04-13 |
2000-05-31 |
Imp College Innovations Ltd |
Vectors for gene therapy
|
US7001760B2
(en)
*
|
2000-04-20 |
2006-02-21 |
Wang-Schick Ryu |
Hepatitis B virus vectors for gene therapy
|
US6583279B1
(en)
|
2001-01-26 |
2003-06-24 |
Becton, Dickinson And Company |
Sequences and methods for detection of hepatitis B virus
|
US7202354B2
(en)
*
|
2001-03-30 |
2007-04-10 |
Abbott Laboratories |
Hepatitis B virus surface antigen mutant and methods of detection thereof
|
GB0217033D0
(en)
|
2002-07-23 |
2002-08-28 |
Delta Biotechnology Ltd |
Gene and polypeptide sequences
|
US8876532B2
(en)
|
2002-07-31 |
2014-11-04 |
Dentsply International Inc. |
Bone repair putty
|
GB0226105D0
(en)
*
|
2002-11-08 |
2002-12-18 |
St Georges S Entpr Ltd |
Pain relief agents
|
GB0304993D0
(en)
*
|
2003-03-05 |
2003-04-09 |
Univ Nottingham Trent |
Novel screening method
|
PL1605971T3
(pl)
*
|
2003-03-26 |
2010-10-29 |
Wyeth Llc |
Kompozycja immunogenna i sposoby
|
EP1702069A2
(en)
*
|
2004-01-05 |
2006-09-20 |
EMD Lexigen Research Center Corp. |
Interleukin-12 targeted to oncofoetal fibronectin
|
GB0420091D0
(en)
*
|
2004-09-10 |
2004-10-13 |
Univ Nottingham Trent |
Medical implant materials
|
US20060193849A1
(en)
*
|
2005-02-25 |
2006-08-31 |
Antisoma Plc |
Biological materials and uses thereof
|
GB0514661D0
(en)
*
|
2005-07-16 |
2005-08-24 |
Medical Res Council |
Methods
|
JP4352032B2
(ja)
|
2005-08-23 |
2009-10-28 |
シャープ株式会社 |
携帯通信機器
|
DK1760089T3
(da)
|
2005-09-05 |
2009-11-16 |
Immatics Biotechnologies Gmbh |
Tumor-associeret peptides bindende til human leukocyte antigen (HLA) class I eller II molecules og relateret anti-cancer vaccine
|
DK1806359T3
(da)
|
2005-09-05 |
2010-06-14 |
Immatics Biotechnologies Gmbh |
Tumorassocierede peptider, der bindes promiskuøst til Humant Leukocyt-Antigen (HLA) klasse II molekyler
|
GB0519398D0
(en)
*
|
2005-09-23 |
2005-11-02 |
Antisoma Plc |
Biological materials and uses thereof
|
GB0607354D0
(en)
*
|
2006-04-12 |
2006-05-24 |
Bioinvent Int Ab |
Agent, Composition And Method
|
GB0607798D0
(en)
*
|
2006-04-20 |
2006-05-31 |
Alligator Bioscience Ab |
Novel polypeptides and use thereof
|
EP2021791A2
(en)
*
|
2006-05-31 |
2009-02-11 |
Unilever N.V. |
Method of screening for compounds that alter skin and/or hair pigmentation
|
KR100836745B1
(ko)
*
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Hbv 백신 및 그의 제조 방법
|
PL2338907T3
(pl)
|
2007-07-27 |
2016-03-31 |
Immatics Biotechnologies Gmbh |
Nowe immunogenne epitopy do immunoterapii
|
PT2660248E
(pt)
|
2007-07-27 |
2015-10-12 |
Immatics Biotechnologies Gmbh |
Nova imunoterapia para tumores neuronais e cerebrais
|
KR101383476B1
(ko)
|
2007-11-01 |
2014-04-11 |
아스테라스 세이야쿠 가부시키가이샤 |
면역억제 폴리펩티드 및 핵산
|
EP2215473A1
(en)
*
|
2007-11-27 |
2010-08-11 |
Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House |
Screening methods
|
CN102851313B
(zh)
*
|
2008-01-28 |
2015-01-28 |
多贝尔有限公司 |
一种乙型肝炎疫苗及其制备工艺
|
ES2554981T3
(es)
|
2008-03-27 |
2015-12-28 |
Immatics Biotechnologies Gmbh |
Nueva inmunoterapia contra tumores neuronales y cerebrales
|
NO2119726T3
(ru)
|
2008-05-14 |
2015-05-23 |
|
|
WO2009158240A1
(en)
|
2008-06-16 |
2009-12-30 |
Emergent Product Development Uk Limited |
Salmonella vectored vaccines against chlamydia and methods of use
|
EP2172211B1
(en)
|
2008-10-01 |
2014-12-03 |
Immatics Biotechnologies GmbH |
Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
|
GB0905790D0
(en)
|
2009-04-03 |
2009-05-20 |
Alligator Bioscience Ab |
Novel polypeptides and use thereof
|
ES2635316T3
(es)
|
2009-12-18 |
2017-10-03 |
Kancera Ab |
Anticuerpos contra ROR1 que pueden inducir muerte celular de LLC
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
GB201019331D0
(en)
|
2010-03-19 |
2010-12-29 |
Immatics Biotechnologies Gmbh |
Methods for the diagnosis and treatment of cancer based on AVL9
|
GB201020995D0
(en)
|
2010-12-10 |
2011-01-26 |
Bioinvent Int Ab |
Biological materials and uses thereof
|
US9452212B2
(en)
|
2011-04-14 |
2016-09-27 |
Dynavax Technologies Corporation |
Methods and compositions for eliciting an immune response against hepatitis B virus
|
GB2490655A
(en)
|
2011-04-28 |
2012-11-14 |
Univ Aston |
Modulators of tissue transglutaminase
|
GB201115280D0
(en)
|
2011-09-05 |
2011-10-19 |
Alligator Bioscience Ab |
Antibodies, uses and methods
|
GB201219678D0
(en)
|
2012-11-01 |
2012-12-12 |
Benf Ab |
Ketone body inhibitors and uses thereof
|
EP3587439A3
(en)
|
2013-03-01 |
2020-03-11 |
Boehringer Ingelheim Animal Health USA Inc. |
Improved quantification of vaccine compositions
|
TWI819228B
(zh)
|
2013-08-05 |
2023-10-21 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類,細胞及其用於治療多種腫瘤的用途,其製造方法及包含其等之醫藥組成物(八)
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
GB201408255D0
(en)
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
GB201411037D0
(en)
|
2014-06-20 |
2014-08-06 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
DK3388075T5
(da)
|
2015-03-27 |
2024-09-23 |
Immatics Biotechnologies Gmbh |
Hidtil ukendte peptider og kombination af peptider til anvendelse ved immunterapi mod forskellige tumorer
|
GB201505585D0
(en)
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
PE20230321A1
(es)
|
2015-07-01 |
2023-02-22 |
Immatics Biotechnologies Gmbh |
Nuevos peptidos y nuevas combinaciones de peptidos para el uso en la inmunoterapia contra el cancer de ovario y otros tipos de cancer
|
CA3221001A1
(en)
|
2015-07-06 |
2017-01-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
GB201522667D0
(en)
|
2015-12-22 |
2016-02-03 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
GB201602918D0
(en)
|
2016-02-19 |
2016-04-06 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
|
IL302705A
(en)
|
2016-03-01 |
2023-07-01 |
Immatics Biotechnologies Gmbh |
Peptides, combinations of peptides, cell-based drugs for use in immunotherapy against bladder cancer and other types of cancer
|
DK3430030T5
(da)
|
2016-03-16 |
2024-09-23 |
Immatics Biotechnologies Gmbh |
Transficerede t-celler og t-cellereceptorer til anvendelse i immunoterapi mod cancer
|
LT3430037T
(lt)
|
2016-03-16 |
2022-12-12 |
Immatics Biotechnologies Gmbh |
Transfekuotos t ląstelės ir t ląstelių receptoriai, skirti naudoti vėžio gydymui taikant imunoterapiją
|
BR112018070067A2
(pt)
|
2016-04-06 |
2019-02-12 |
Immatics Biotechnologies Gmbh |
peptídeos e combinações de peptídeos para uso em imunoterapia contra lma e outros cânceres
|
TWI796299B
(zh)
|
2016-08-26 |
2023-03-21 |
德商英麥提克生物技術股份有限公司 |
用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架
|
WO2018138257A1
(en)
|
2017-01-27 |
2018-08-02 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
CA3059644A1
(en)
|
2017-04-10 |
2018-10-18 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
US11427614B2
(en)
|
2017-04-10 |
2022-08-30 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
TW201841937A
(zh)
|
2017-04-10 |
2018-12-01 |
德商英麥提克生物技術股份有限公司 |
用於白血病和其他癌症免疫治療的新穎肽和肽組合物
|
EP4316597A2
(en)
|
2017-07-07 |
2024-02-07 |
immatics biotechnologies GmbH |
Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers
|
US10800823B2
(en)
|
2017-07-07 |
2020-10-13 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
|
DE102018107224A1
(de)
|
2018-02-21 |
2019-08-22 |
Immatics Biotechnologies Gmbh |
Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten
|
TW202016131A
(zh)
|
2018-05-16 |
2020-05-01 |
德商英麥提克生物技術股份有限公司 |
用於抗癌免疫治療的肽
|
US10925947B2
(en)
|
2018-06-29 |
2021-02-23 |
Immatics Biotechnologies Gmbh |
A*03 restricted peptides for use in immunotherapy against cancers and related methods
|
TW202019955A
(zh)
|
2018-07-31 |
2020-06-01 |
德商英麥提克生物技術股份有限公司 |
B*07 限制肽和肽組合的抗癌免疫治療和相關方法
|
US11945850B2
(en)
|
2018-09-17 |
2024-04-02 |
Immatics Biotechnologies Gmbh |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
|
TW202024121A
(zh)
|
2018-09-18 |
2020-07-01 |
德商英麥提克生物技術股份有限公司 |
A*01 限制肽和肽組合物在抗癌免疫治療中的用途和相關方法
|
TW202039535A
(zh)
|
2018-12-18 |
2020-11-01 |
德商英麥提克生物技術股份有限公司 |
B*08限制肽和肽組合物抗癌免疫治療和相關方法
|
DE102020125457A1
(de)
|
2020-09-29 |
2022-03-31 |
Immatics Biotechnologies Gmbh |
Amidierte Peptide und ihre deamidierten Gegenstücke, die durch HLA-A*02-Moleküle präsentiert werden, zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten
|
TW202229312A
(zh)
|
2020-09-29 |
2022-08-01 |
德商英麥提克生物技術股份有限公司 |
由非hla-a*02顯露以用於不同類型癌症之免疫治療的醯胺化肽及其脫醯胺化對應物
|
TW202241925A
(zh)
|
2021-01-15 |
2022-11-01 |
德商英麥提克生物技術股份有限公司 |
用於不同類型癌症免疫治療的hla展示肽
|